Cardio Diagnostics Holdings, Inc. (CDIO)
(Delayed Data from NSDQ)
$0.77 USD
+0.07 (10.35%)
Updated May 3, 2024 04:00 PM ET
After-Market: $0.77 0.00 (0.42%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Price, Consensus and EPS Surprise
CDIO 0.77 +0.07(10.35%)
Will CDIO be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for CDIO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for CDIO
Cardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD™ Test Could Save Health Insurers Over $113 Million Annually
Cardio Diagnostics : PrecisionCHD test may save insurers $13M annually
12 Health Care Stocks Moving In Friday's Intraday Session
Cardio Diagnostics price target lowered by $2.65 at Benchmark, here's why
12 Health Care Stocks Moving In Monday's After-Market Session